Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ABI-H2158 plus entecavir in chronic hepatitis B
CTR20202700Phase 2Terminated
- Sponsor
- AustarPharma
- Start
- Jan 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of firzacorvir in Chronic Hepatitis B (CHB), sponsored by AustarPharma. Started Jan 2021; status: terminated.
02
Drugs
firzacorvir
03
Conditions
Chronic Hepatitis B (CHB)
Beyond the preview
Go deeper on CTR20202700.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20202700.